June 2025

Dr. Oluwatosin Smith Advocates Early Glaucoma Care at ASCRS 2025 At the prestigious American Society of Cataract and Refractive Surgery (ASCRS) 2025 conference, renowned ophthalmologist Dr. Oluwatosin Smith delivered a compelling keynote address on the critical importance of early glaucoma detection and intervention. With glaucoma being a leading cause of irreversible blindness worldwide, Dr. Smith’s […]

Enhanced IOP Control with Anti-VEGF and MMC Surgical Therapy Managing intraocular pressure (IOP) is a critical aspect of treating glaucoma and other ocular conditions that threaten vision. Traditional surgical interventions, while effective, often come with complications such as scarring and inflammation. However, combining anti-VEGF (vascular endothelial growth factor) therapy with mitomycin C (MMC) surgical therapy

Preventable Glaucoma Vision Loss Hindered by Treatment Costs Glaucoma, often called the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. Shockingly, much of the vision loss caused by this condition is preventable—if detected early and treated properly. However, a major barrier stands in the way: the high cost of treatment. Many

Optic Nerve Hemoglobin Levels Impact Glaucoma Structure and Function Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive damage to the optic nerve and retinal ganglion cells. While elevated intraocular pressure (IOP) has long been recognized as a major risk factor, emerging research suggests that optic nerve hemoglobin levels may play a